Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 12,469 | 6,197 | 379 | 6,499 | 11,419 |
| Gross Profit | 12,469 | 6,197 | 379 | 6,499 | 11,419 |
| Operating Expenses | 54,078 | 45,450 | 55,780 | 63,382 | 77,293 |
| Operating Income | -41,609 | -39,253 | -55,401 | -56,883 | -65,874 |
| Interest Expense | 0 | -19 | 1 | -21 | -8,921 |
| Other Income | 173 | 152 | 146 | 134 | -5,546 |
| Pre-tax Income | -41,436 | -39,082 | -55,256 | -56,728 | -62,499 |
| Net Income Continuous | -41,436 | -39,082 | -55,256 | -56,728 | -62,499 |
| Net Income | $-41,436 | $-39,082 | $-55,256 | $-56,728 | $-62,499 |
| EPS Basic Total Ops | -0.61 | -0.57 | -0.81 | -0.86 | -0.99 |
| EPS Basic Continuous Ops | -0.60 | -0.57 | -0.81 | -0.86 | -0.99 |
| EPS Diluted Total Ops | -0.61 | -0.57 | -0.81 | -0.86 | -0.98 |
| EPS Diluted Continuous Ops | -0.60 | -0.57 | -0.81 | -0.86 | -0.99 |
| EBITDA(a) | $-38,441 | $-38,063 | $-54,212 | $-55,720 | $-64,691 |